• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • All Posts
  • Contact

Time Restricted

Experiences with Time-Restricted Eating and Managing Chronic Disease

Is too much “good cholesterol” bad for you?

December 27, 2018 By spao Leave a Comment

Is too much “good cholesterol” bad for you?

A good friend just pointed me to an interesting article from the New York Times that came out Christmas Eve Day.

It was based on a study out of Emory University in Atlanta that showed higher all-cause mortality associated with HDL levels above 80!  Below is a screen capture from the press conference where the study results were presented showing “U curve” associated with adverse events with both low HDL (<40 mg/DL) and very high HDL (>80 mg/DL).

HDL-U-Shaped-Curve
Risks of mortality are higher with very low AND very high levels of HDL

The authors acknowledge some limitations of the study.  The study started with patients that already had severe heart disease and speculate there may be some reverse causation.  They also recognize that genetic mutations may be at play, citing LIPG, SCARB1, and CETP (which mean nothing to me right now!)

The recommendations were very nuanced.

HDL-Nuanced-Recommendations
Because the mechanism of high HDL and higher mortality is not known, the recommendation is to focus on risk factors we can control.

Because the mechanisms remain unclear as to why high HDL levels are associated with adverse events, they recommend focusing on the mechanisms we do know about!  Still, this is the first data point I’ve seen speculating that HDL might not be protective at very high levels.  This will be very interesting data to watch going forward!

The video of the press conference is accessible here.

Filed Under: Diabetes

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • Sharing the Good & Bad of Ozempic on Medium
  • Why I stopped taking Vitamin B supplements
  • What changes when you progress from chronic kidney disease stage 3B to stage 4?
  • Ozempic treats diabetes (but I didn’t lose weight!)
  • Glucose might not be the cause of Type 2 Diabetes

Archives

  • February 2025
  • December 2024
  • August 2024
  • November 2019
  • October 2019
  • June 2019
  • May 2019
  • December 2018
  • November 2018
  • September 2018
  • August 2018

Categories

  • Buchinger-Wilhelmi
  • Buchinger-Wilhelmi 2019
  • Chronic Kidney Disease
  • Diabetes
  • Fasting
  • Featured

Sign up for updates to Time-Restricted

Footer

Stephen Pao is the author of the Time-Restricted blog. Following a Type II diabetes diagnosis in 2003, Steve began experimenting with alternative approaches to managing the disease, including prolonged fasting as a complement to a low-carb lifestyle. Several years ago, Steve also added a more involved drug program, including Ozempic and Jardiance. By day, Steve is a consultant and board advisor to early stage technology companies. Steve and his wife are empty nesters, with two adult daughters.

Copyright © 2025 · Workstation Pro On Genesis Framework · WordPress · Log in